KEI Briefing Note 2020:1 Role of the U.S. Federal Government in the Development of GS-5734/Remdesivir

KEI Briefing Note 2020:1: Role of the U.S. Federal Government in the Development of GS-5734/Remdesivir
Kathryn Ardizzone. March 20, 2020.

KEI-Briefing-Note-2020_1GS-5734-Remdesivir